You have tried the low-FODMAP diet. You have tried loperamide for the diarrhea. You may have tried a bile acid sequestrant or an antispasmodic. Your IBS-D symptoms have not resolved. Before escalating to more aggressive IBS therapies, there is a test worth ordering that most IBS workups skip entirely: fecal elastase-1. This single stool test measures the output of your pancreas. If your pancreas is not producing enough digestive enzymes, no amount of dietary modification or antidiarrheal medication will fix the underlying problem. About 6% of patients meeting IBS criteria have fecal elastase values consistent with pancreatic exocrine insufficiency. For those patients, enzyme replacement therapy is the treatment, not IBS management. This guide covers the specific tests, how to interpret results, the treatment protocol, and how to monitor your response.
When should you consider PEI testing?
There is no official guideline mandating fecal elastase testing in IBS patients, but clinical reasoning supports testing in several scenarios. PEI testing is warranted if you have been following IBS-D treatments consistently for 3 or more months without adequate symptom control, if your stools are persistently loose, fatty-appearing, foul-smelling, or difficult to flush, if you have unintentional weight loss alongside chronic diarrhea, if you have a history of chronic pancreatitis, heavy alcohol use, pancreatic surgery, cystic fibrosis, or diabetes, if you developed chronic diarrhea after gallbladder removal, if you are over 65 with new-onset GI symptoms, or if you have unexplained fat-soluble vitamin deficiencies (especially low vitamin D despite supplementation).
The decision point is similar to other missed diagnoses: if treatments targeting IBS are not working, the diagnosis may be incomplete. Testing pancreatic function is a low-cost, low-risk next step that can identify a treatable cause.
Fecal elastase-1: the primary test
Fecal elastase-1 is a pancreas-specific enzyme that passes through the GI tract without significant degradation. Its concentration in stool reflects pancreatic enzyme output. The test requires a single stool sample, collected at home or in a lab setting. No fasting, dietary preparation, or medication changes are needed before collection. The sample is sent to a laboratory, and results are typically available within 3-7 business days.
Interpreting fecal elastase results
Result Ranges
- Above 200 mcg/g: Normal pancreatic function. PEI is unlikely (though not completely excluded in rare cases).
- 100-200 mcg/g: Moderate PEI. The pancreas is producing reduced enzyme levels. Symptoms of fat malabsorption are expected. PERT is typically recommended.
- Below 100 mcg/g: Severe PEI. The pancreas is producing very low enzyme levels. Significant fat malabsorption and nutritional deficiencies are likely. PERT is strongly indicated, and imaging to evaluate pancreatic structure (CT or MRI) is typically recommended.
The fecal elastase test has a sensitivity of 73-100% for moderate to severe PEI and specificity of 80-96%. It is less reliable for mild PEI, where some patients with borderline enzyme output will test in the normal range. A key technical consideration: very watery stool can dilute elastase concentration, potentially producing a falsely low result. If your stools are consistently liquid, discuss this with your provider. Testing on a more formed sample, if possible, improves accuracy.
âšī¸Fecal elastase-1 measures pancreatic output. It does not measure the total enzyme activity in your intestine. Patients taking over-the-counter digestive enzyme supplements do not need to stop them before the test because fecal elastase-1 is specific to the pancreas and is not affected by non-pancreatic enzyme products.
Additional testing: fat-soluble vitamin panel
If fecal elastase confirms PEI, the next step is checking for nutritional consequences. Chronic fat malabsorption impairs absorption of vitamins A, D, E, and K, which require dietary fat for absorption. A fat-soluble vitamin panel should be ordered alongside or shortly after a PEI diagnosis.
- Vitamin D (25-hydroxyvitamin D). The most commonly deficient in PEI. Chronic deficiency leads to osteopenia and osteoporosis. Levels below 30 ng/mL warrant supplementation.
- Vitamin A (retinol). Deficiency can cause night blindness and impaired immune function, though frank deficiency is uncommon in mild PEI.
- Vitamin E (alpha-tocopherol). Deficiency can contribute to neurological symptoms and increased oxidative stress.
- Vitamin K (phylloquinone). Deficiency impairs blood clotting. It is less commonly measured but should be checked if there is easy bruising or bleeding.
Some clinicians also check prealbumin and albumin as markers of protein nutrition, and magnesium and zinc levels, which can be secondarily affected by malabsorption. A DEXA scan for bone density may be recommended for patients with long-standing PEI or documented vitamin D deficiency.
Additional testing: pancreatic imaging
When fecal elastase confirms PEI, particularly severe PEI (below 100 mcg/g), imaging to evaluate pancreatic structure is appropriate. CT scan or MRI of the abdomen can reveal chronic pancreatitis (calcifications, ductal changes, atrophy), pancreatic masses, ductal obstructions, or structural abnormalities. Endoscopic ultrasound (EUS) provides detailed imaging of the pancreatic parenchyma and ducts and is the most sensitive tool for detecting early chronic pancreatitis. Imaging is not always necessary for patients with known pancreatic conditions (established chronic pancreatitis, prior surgery) but is important when PEI is found unexpectedly in a patient without a clear cause.
PERT: how enzyme replacement works
Pancreatic enzyme replacement therapy provides the lipase, amylase, and protease that the pancreas is not producing in sufficient quantities. PERT capsules contain thousands of enteric-coated microspheres (or minimicrotablets) that are designed to survive stomach acid and release enzymes in the duodenum, where they mix with food and begin digesting fat, carbohydrates, and protein.
Dosing protocol
Standard initial dosing is 40,000-50,000 lipase units per meal and 20,000-25,000 lipase units per snack. Enzymes should be taken with food, not before or after. The recommended approach is to take half the dose at the start of the meal and half midway through, which optimizes enzyme-chyme mixing. Capsules should be swallowed whole with water. If swallowing capsules is difficult, they can be opened and the microspheres sprinkled on acidic food (applesauce) and swallowed without chewing, since crushing the microspheres destroys the enteric coating.
If symptoms do not improve adequately at the starting dose, the dose can be increased. Doses up to 75,000-80,000 lipase units per meal are used in severe PEI. If high-dose PERT still does not resolve symptoms, adding a proton pump inhibitor may help by reducing gastric acid that can degrade enzymes before they reach the duodenum. Persistent symptoms despite adequate PERT dosing should prompt evaluation for other contributing conditions (SIBO, bile acid malabsorption, celiac disease).
| Severity | Fecal Elastase | Starting PERT Dose (per meal) | Monitoring |
|---|---|---|---|
| Moderate PEI | 100-200 mcg/g | 40,000 lipase units | Symptom response, stool quality |
| Severe PEI | Below 100 mcg/g | 50,000 lipase units | Symptom response, vitamin levels, weight |
What helps with tracking symptoms during testing and treatment?
The period surrounding PEI testing and PERT initiation is critical to document. Your doctor needs to assess whether enzyme replacement is working, and clear symptom data makes that assessment more reliable. Track stool frequency, consistency, and appearance (noting any oily or floating stools), along with bloating severity, pain levels, and dietary intake, especially fat content. The GLP1Gut app can simplify this by logging meals, stool characteristics, and symptoms in one place, creating a record your provider can review when adjusting PERT dosing. Start tracking at least 1-2 weeks before your fecal elastase test so you have a baseline to compare against your post-treatment response.
Frequently Asked Questions
How much does fecal elastase testing cost?
A fecal elastase-1 test typically costs $50-200 depending on the laboratory and insurance coverage. Most insurance plans cover it when ordered by a physician with a clinical indication (chronic diarrhea, suspected malabsorption). It is one of the least expensive GI diagnostic tests available.
Do I need to stop taking digestive enzymes before the fecal elastase test?
Over-the-counter digestive enzyme supplements do not need to be stopped because fecal elastase-1 is specific to the pancreas. However, if you are already taking prescription PERT (Creon, Zenpep, Pancreaze), discuss timing with your doctor, as interpretation may differ if you are on active enzyme replacement.
How quickly does PERT work?
Most patients notice improvement in stool quality within 2-5 days of starting PERT at appropriate doses. Bloating and gas may take 1-2 weeks to improve. Fat-soluble vitamin levels take longer to normalize, often 2-3 months of consistent enzyme replacement and supplementation. If you see no improvement within 2 weeks, discuss dose adjustment with your provider.
Are there side effects to PERT?
PERT is generally well tolerated. The most common side effects are mild GI symptoms: nausea, abdominal discomfort, and constipation at higher doses. Extremely high doses (above 10,000 lipase units per kilogram per meal) carry a theoretical risk of fibrosing colonopathy, but this is primarily a concern in cystic fibrosis patients on very high doses. Standard dosing for adult PEI is well within safe limits.
Can PEI be diagnosed by blood test?
There is no reliable blood test that directly diagnoses PEI. Blood tests can detect consequences of PEI (low vitamin D, low vitamin A, low prealbumin), but fecal elastase-1 measured in stool is the standard non-invasive diagnostic test. Serum trypsinogen and lipase levels are sometimes used but are less reliable for diagnosing mild to moderate PEI.
â ī¸This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition.